- Home
- KBDC vs OPK Comparison
KBDC vs OPK Comparison
Compare KBDC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBDC
- OPK
- Stock Information
- Founded
- KBDC 2021
- OPK 2007
- Country
- KBDC United States
- OPK United States
- Employees
- KBDC N/A
- OPK N/A
- Industry
- KBDC
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- KBDC
- OPK Health Care
- Exchange
- KBDC Nasdaq
- OPK Nasdaq
- Market Cap
- KBDC 1.2B
- OPK 1.0B
- IPO Year
- KBDC N/A
- OPK 1995
- Fundamental
- Price
- KBDC $17.34
- OPK $1.58
- Analyst Decision
- KBDC Buy
- OPK Strong Buy
- Analyst Count
- KBDC 5
- OPK 3
- Target Price
- KBDC $17.30
- OPK $2.75
- AVG Volume (30 Days)
- KBDC 104.3K
- OPK 2.9M
- Earning Date
- KBDC 03-03-2025
- OPK 02-25-2025
- Dividend Yield
- KBDC 2.31%
- OPK N/A
- EPS Growth
- KBDC N/A
- OPK N/A
- EPS
- KBDC N/A
- OPK N/A
- Revenue
- KBDC N/A
- OPK $711,408,000.00
- Revenue This Year
- KBDC $193.84
- OPK N/A
- Revenue Next Year
- KBDC $15.95
- OPK $0.00
- P/E Ratio
- KBDC N/A
- OPK N/A
- Revenue Growth
- KBDC N/A
- OPK N/A
- 52 Week Low
- KBDC $15.69
- OPK $0.86
- 52 Week High
- KBDC $17.34
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- KBDC N/A
- OPK 55.91
- Support Level
- KBDC N/A
- OPK $1.47
- Resistance Level
- KBDC N/A
- OPK $1.51
- Average True Range (ATR)
- KBDC 0.00
- OPK 0.04
- MACD
- KBDC 0.00
- OPK 0.01
- Stochastic Oscillator
- KBDC 0.00
- OPK 94.44
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.